Announced Tue, 28 Apr · 14:39 IST
Initial Disclosure by Entity Identified as Large Corporate
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+6.5%1-day move
₹77.00
prior close
₹82.90
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.0+6.5+5.2+2.6+2.1+6.9+7.8+2.1+6.4-3.2—
Up moveDown movePending
AI summary
Ishita Drugs & Industries Ltd has submitted the initial disclosure required from entities identified as Large Corporates under SEBI/BSE norms. Large Corporate status is typically based on outstanding borrowings exceeding prescribed thresholds. This disclosure outlines the company's funding plans and its intent to raise a portion of its borrowing needs through the capital market. The actual filing details could not be retrieved as the BSE page was unavailable.
Likely market impact
Routine compliance filing; unlikely to materially impact stock price or shareholder value. Indicates borrowing levels qualify the company as a Large Corporate.